386 related articles for article (PubMed ID: 16284097)
1. Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors.
Theander E; Henriksson G; Ljungberg O; Mandl T; Manthorpe R; Jacobsson LT
Ann Rheum Dis; 2006 Jun; 65(6):796-803. PubMed ID: 16284097
[TBL] [Abstract][Full Text] [Related]
2. Mortality and causes of death in primary Sjögren's syndrome: a prospective cohort study.
Theander E; Manthorpe R; Jacobsson LT
Arthritis Rheum; 2004 Apr; 50(4):1262-9. PubMed ID: 15077310
[TBL] [Abstract][Full Text] [Related]
3. Risk, predictors, and clinical characteristics of lymphoma development in primary Sjögren's syndrome.
Solans-Laqué R; López-Hernandez A; Bosch-Gil JA; Palacios A; Campillo M; Vilardell-Tarres M
Semin Arthritis Rheum; 2011 Dec; 41(3):415-23. PubMed ID: 21665245
[TBL] [Abstract][Full Text] [Related]
4. Predicting the outcome of Sjogren's syndrome-associated non-hodgkin's lymphoma patients.
Papageorgiou A; Ziogas DC; Mavragani CP; Zintzaras E; Tzioufas AG; Moutsopoulos HM; Voulgarelis M
PLoS One; 2015; 10(2):e0116189. PubMed ID: 25723713
[TBL] [Abstract][Full Text] [Related]
5. Elevated incidence of hematologic malignancies in patients with Sjögren's syndrome compared with patients with rheumatoid arthritis (Finland).
Kauppi M; Pukkala E; Isomäki H
Cancer Causes Control; 1997 Mar; 8(2):201-4. PubMed ID: 9134244
[TBL] [Abstract][Full Text] [Related]
6. Characterization and risk estimate of cancer in patients with primary Sjögren syndrome.
Brito-Zerón P; Kostov B; Fraile G; Caravia-Durán D; Maure B; Rascón FJ; Zamora M; Casanovas A; Lopez-Dupla M; Ripoll M; Pinilla B; Fonseca E; Akasbi M; de la Red G; Duarte-Millán MA; Fanlo P; Guisado-Vasco P; Pérez-Alvarez R; Chamorro AJ; Morcillo C; Jiménez-Heredia I; Sánchez-Berná I; López-Guillermo A; Ramos-Casals M;
J Hematol Oncol; 2017 Apr; 10(1):90. PubMed ID: 28416003
[TBL] [Abstract][Full Text] [Related]
7. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome.
Ioannidis JP; Vassiliou VA; Moutsopoulos HM
Arthritis Rheum; 2002 Mar; 46(3):741-7. PubMed ID: 11920410
[TBL] [Abstract][Full Text] [Related]
8. Primary Sjögren's syndrome is associated with increased risk of malignancies besides lymphoma: A systematic review and meta-analysis.
Zhong H; Liu S; Wang Y; Xu D; Li M; Zhao Y; Zeng X
Autoimmun Rev; 2022 May; 21(5):103084. PubMed ID: 35341972
[TBL] [Abstract][Full Text] [Related]
9. Low miR200b-5p levels in minor salivary glands: a novel molecular marker predicting lymphoma development in patients with Sjögren's syndrome.
Kapsogeorgou EK; Papageorgiou A; Protogerou AD; Voulgarelis M; Tzioufas AG
Ann Rheum Dis; 2018 Aug; 77(8):1200-1207. PubMed ID: 29779010
[TBL] [Abstract][Full Text] [Related]
10. CD4+ T-lymphocytopenia--a frequent finding in anti-SSA antibody seropositive patients with primary Sjögren's syndrome.
Mandl T; Bredberg A; Jacobsson LT; Manthorpe R; Henriksson G
J Rheumatol; 2004 Apr; 31(4):726-8. PubMed ID: 15088298
[TBL] [Abstract][Full Text] [Related]
11. Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects.
Baimpa E; Dahabreh IJ; Voulgarelis M; Moutsopoulos HM
Medicine (Baltimore); 2009 Sep; 88(5):284-293. PubMed ID: 19745687
[TBL] [Abstract][Full Text] [Related]
12. Ectopic Germinal Center-Like Structures in Minor Salivary Gland Biopsy Tissue Predict Lymphoma Occurrence in Patients With Primary Sjögren's Syndrome.
Sène D; Ismael S; Forien M; Charlotte F; Kaci R; Cacoub P; Diallo A; Dieudé P; Lioté F
Arthritis Rheumatol; 2018 Sep; 70(9):1481-1488. PubMed ID: 29669392
[TBL] [Abstract][Full Text] [Related]
13. [The relationship between Sjogren's syndrome, systemic sclerosis and lymphoproliferative diseases].
Vasil'ev VI; Chal'tsev BD; Gorodetskii VR; Pal'shina SG; Shornikova NS; Anan'eva LP; Gaiduk IV; Kokosadze NV; Probatova NA; Pavlovskaia AI; Rodionova EB; Safonova TN; Balabina AA
Ter Arkh; 2020 Dec; 92(12):126-136. PubMed ID: 33720584
[TBL] [Abstract][Full Text] [Related]
14. [Characteristics of patients with primary Sjögren's syndrome and non-Hodgkin's lymphoma: analysis of 9 cases].
Jia N; Tang FL
Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(39):2786-8. PubMed ID: 20137605
[TBL] [Abstract][Full Text] [Related]
15. Risk of malignancy in Korean patients with primary Sjögren's syndrome.
Kang J; Kim H; Kim J; Choi S; Jung SY; Jang EJ; Cho SK; Sung YK
Int J Rheum Dis; 2020 Aug; 23(9):1240-1247. PubMed ID: 32841507
[TBL] [Abstract][Full Text] [Related]
16. [Characteristics of the patients with primary Sjögren's syndrome complicated with lymphoma].
Li YQ; Yu QM; Li J; Yang JR; Niu T
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 May; 43(3):467-9. PubMed ID: 22812260
[TBL] [Abstract][Full Text] [Related]
17. Non-Hodgkin's lymphoma associated with primary Sjögren's syndrome.
Pariente D; Anaya JM; Combe B; Jorgensen C; Emberger JM; Rossi JF; Sany J
Eur J Med; 1992 Oct; 1(6):337-42. PubMed ID: 1341461
[TBL] [Abstract][Full Text] [Related]
18. Differential risk of non-Hodgkin's lymphoma in Italian patients with primary Sjögren's syndrome.
Valesini G; Priori R; Bavoillot D; Osborn J; Danieli MG; Del Papa N; Gerli R; Pietrogrande M; Sabbadini MG; Silvestris F; Valsecchi L
J Rheumatol; 1997 Dec; 24(12):2376-80. PubMed ID: 9415645
[TBL] [Abstract][Full Text] [Related]
19. The P2X7 receptor-NLRP3 inflammasome complex predicts the development of non-Hodgkin's lymphoma in Sjogren's syndrome: a prospective, observational, single-centre study.
Baldini C; Santini E; Rossi C; Donati V; Solini A
J Intern Med; 2017 Aug; 282(2):175-186. PubMed ID: 28503820
[TBL] [Abstract][Full Text] [Related]
20. Role of Fms-like tyrosine kinase 3 ligand as a potential biologic marker of lymphoma in primary Sjögren's syndrome.
Tobón GJ; Saraux A; Gottenberg JE; Quartuccio L; Fabris M; Seror R; Devauchelle-Pensec V; Morel J; Rist S; Mariette X; De Vita S; Youinou P; Pers JO
Arthritis Rheum; 2013 Dec; 65(12):3218-27. PubMed ID: 23982978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]